Tango Therapeutics, Inc. (TNGX)
23.78
+0.41
(+1.75%)
USD |
NASDAQ |
Sep 11, 16:00
23.76
-0.02
(-0.08%)
After-Hours: 20:00
Tango Therapeutics Market Cap : 4.004B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.004B |
| September 10, 2026 | 3.935B |
| September 09, 2026 | 4.041B |
| September 08, 2026 | 3.822B |
| September 04, 2026 | 3.792B |
| September 03, 2026 | 3.832B |
| September 02, 2026 | 3.758B |
| September 01, 2026 | 3.763B |
| August 31, 2026 | 3.846B |
| August 28, 2026 | 3.930B |
| August 27, 2026 | 4.257B |
| August 26, 2026 | 4.289B |
| August 25, 2026 | 4.171B |
| August 24, 2026 | 4.127B |
| August 21, 2026 | 4.021B |
| August 20, 2026 | 3.959B |
| August 19, 2026 | 4.243B |
| August 18, 2026 | 4.284B |
| August 17, 2026 | 4.258B |
| August 14, 2026 | 4.311B |
| August 13, 2026 | 4.319B |
| August 12, 2026 | 4.307B |
| August 11, 2026 | 4.435B |
| August 10, 2026 | 4.659B |
| August 07, 2026 | 4.558B |
| Date | Value |
|---|---|
| August 06, 2026 | 4.883B |
| August 05, 2026 | 4.150B |
| August 04, 2026 | 4.233B |
| August 03, 2026 | 3.923B |
| July 31, 2026 | 3.918B |
| July 30, 2026 | 3.975B |
| July 29, 2026 | 3.727B |
| July 28, 2026 | 3.842B |
| July 27, 2026 | 3.852B |
| July 24, 2026 | 3.839B |
| July 23, 2026 | 3.957B |
| July 22, 2026 | 4.051B |
| July 21, 2026 | 4.184B |
| July 20, 2026 | 3.970B |
| July 17, 2026 | 4.117B |
| July 16, 2026 | 3.985B |
| July 15, 2026 | 4.361B |
| July 14, 2026 | 4.274B |
| July 13, 2026 | 4.088B |
| July 10, 2026 | 4.478B |
| July 09, 2026 | 4.400B |
| July 08, 2026 | 4.417B |
| July 07, 2026 | 4.342B |
| July 06, 2026 | 4.316B |
| July 02, 2026 | 4.247B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 43.66B |
| Beam Therapeutics, Inc. | 2.477B |
| Erasca, Inc. | 4.963B |
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 11.92M |
Market Cap Related Metrics
| PS Ratio | 59.22 |
| Price to Book Value | 3.908 |
| Price | 23.78 |
| Earnings Yield | -3.52% |